Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
Milliardenmarkt Quantensicherheit! Ist diese Aktie noch völlig unterschätzt?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ZL

WKN: A3EGH0 | ISIN: CA9899601095 | Ticker:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ZYUS LIFE SCIENCES CORPORATION Chart 1 Jahr
5-Tage-Chart
ZYUS LIFE SCIENCES CORPORATION 5-Tage-Chart

Aktuelle News zur ZYUS LIFE SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ZYUS LIFE SCIENCES Aktie jetzt für 0€ handeln
07.11.ZYUS Life Sciences Announces Closing of Second Tranche of Non-Brokered Unit Offering Private Placement2
07.11.Zyus Life Sciences Corp: Zyus closes $50,000 second tranche of placement1
22.10.Zyus Life Sciences Corp: Zyus Life closes $200,000 first tranche of financing1
22.10.ZYUS Life Sciences Announces Closing of First Tranche of Non-Brokered Unit Offering Private Placement1
02.10.Zyus Life Sciences Corp: Zyus releases phase 2a results for Trichomylin3
01.10.ZYUS meldet Ergebnisse aus Phase-2a-Studie zur Behandlung von Krebsschmerzen1
01.10.ZYUS reports phase 2a trial results for cancer pain treatment1
01.10.ZYUS Life Sciences Corporation: ZYUS Life Sciences Announces Positive Topline Results from Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug in Patients with Advanced Cancer428Phase 2a UTOPIA-1 trial results showed Trichomylin® softgel capsules demonstrated clinically relevant efficacy signals using multiple pain assessments. Trichomylin®...
► Artikel lesen
25.09.Zyus Life Sciences Corp: Zyus to release phase 2a Utopia-1 results Sept. 301
25.09.ZYUS Life Sciences Corporation Announces Planned Release Date for Phase 2a Clinical Trial Results, Annual General Meeting Results and Change in Audit Committee Chair4
15.09.Zyus Life Sciences Corp: Zyus Life Sciences appoints Knowles as interim CFO3
15.09.ZYUS Life Sciences Corporation Provides General Business Update and Announces Changes in Executive Leadership1
12.09.Zyus Life Sciences Corp: Zyus Life Sciences closes $50,000 debt financing1
12.09.ZYUS Life Sciences Announces Closing of Debt Financing1
10.09.ZYUS Life Sciences Corporation Provides Liquidity and Working Capital Update and Announces Reinstatement to Trading3
01.09.ZYUS Life Sciences Corporation Announces Completion of Secured Loan Financing2
19.08.Zyus Life Sciences Corp: Zyus closes $275,000 ninth tranche of loan financing2
19.08.ZYUS Life Sciences Corporation Announces Closing of Ninth Tranche of Secured Loan Financing1
14.08.Zyus Life Sciences Corp: Zyus unit closes $550,000 8th tranche of loan financing1
14.08.ZYUS Life Sciences Corporation Announces Closing of Eighth Tranche of Secured Loan Financing and Amendment to Unsecured Promissory Note1
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1